Purchase Order 75N94019P00156
Award Date 12/28/18
Potential Completion Date 12/31/19
Potential Value $97K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Child Health and Human Development to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The $105,592.48 award does not have a set-aside designation. Illumina has previously received prime federal contracts and sub-grants from various agencies like the NIH, Centers for Disease Control, Department of...
- This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
- This is a firm fixed price purchase order awarded by the National Institute of Child Health and Human Development, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for $80,547.47 to provide Illumina reagent kits. The award has a ceiling value of $81,551.80 and an ultimate completion date of September 30, 2024. This purchase order was issued under a Special Notice solicitation that was not set aside for any specific business category. Illumina is a...
- This firm fixed-price delivery order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Child Health and Human Development to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and consumables. The $161,545.56 award is for the provision of Illumina sequencing kits and reagents to support genomic analysis and research. While no set-aside designation was used, Illumina has an extensive history of providing...
- This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, an agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $12,103.44 contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. Illumina provides a range of genomic sequencing platforms, reagents, consumables, and maintenance services to support...
- This firm fixed-price delivery order contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and bioinformatics products. The $131,931.29 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related goods and services to support genomic research and analysis. This award is not associated with a set-aside...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $146,839.68 contract has a completion date of September 2, 2025 and does not have a set-aside designation. Illumina has previously received federal prime contracts and subcontracts from agencies such as NIH, CDC, USDA, and VA to...
- This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...